Four drugmakers filed motions for summary judgement in their lawsuits challenging HRSA's opposition to their 340B rebate proposals in the U.S. District Court for the District of Columbia.
Drugmakers Push Court to Quickly Strike Down HRSA’s Opposition to 340B Rebates